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ABSTRACT
Transcription factors (TFs) regulate gene expression
by binding to short DNA sequence motifs, yet their
binding specificities alone cannot explain how
certain TFs drive a diversity of biological processes.
In order to investigate the factors that control the
functions of the pleiotropic TF STAT3, we studied
its genome-wide binding patterns in four different
cell types: embryonic stem cells, CD4+ T cells,
macrophages and AtT-20 cells. We describe for the
first time two distinct modes of STAT3 binding. First,
a small cell type-independent mode represented by a
set of 35 evolutionarily conserved STAT3-binding
sites that collectively regulate STAT3’s own func-
tions and cell growth. We show that STAT3 is re-
cruited to sites with E2F1 already pre-bound before
STAT3 activation. Second, a series of different tran-
scriptional regulatory modules (TRMs) assemble
around STAT3 to drive distinct transcriptional
programs in the four cell types. These modules rec-
ognize cell type-specific binding sites and are
associated with factors particular to each cell type.
Our study illustrates the versatility of STAT3 to
regulate both universal- and cell type-specific func-
tions by means of distinct TRMs, a mechanism that
might be common to other pleiotropic TFs.
INTRODUCTION
The precise spatio-temporal regulation of gene expression
programs determines an organism’s development and the
interaction with its environment. Transcription factors
(TFs) control this process by binding to short DNA se-
quences (typically 6–8 bp), yet their binding specificities
cannot explain the various cell type-specific functions of
many TFs. Protein binding microarrays have shown that
members of TF families such as homeodomains bind to
very similar sequences, which therefore cannot account on
their own for the enormous diversity of functional roles of
homeodomain TFs during animal development (1,2).
Potentially, cell type specificity emerges from the interplay
of TF DNA sequence specificity, co-factors and epigen-
etics (3). However, despite vast efforts to understand the
mechanisms that determine cell type-specific TF activity,
the exact mechanisms continue to remain frustratingly
elusive. A number of studies have shown that key TFs
associate locally with co-activators to constitute ‘tran-
scriptional regulatory modules’ (TRMs) that endow the
key TF with cell type-specific functions. An important
example was provided in embryonic stem cells (ESCs),
where TFs assemble around the core heterodimer
SOX2-OCT4 and NANOG (4). In hematopoietic progeni-
tor cells, the TRM centers around GATA2, RUNX1 and
SCL/TAL1 (5), whereas in developing B cells the TRM
clusters around E2A, EBF1 and FOXO1 (6). Finally, in
trophectoderm stem cells, the TF core around which the
TRM assembles includes SMARCA4, EOMES,
TCFAP2A, GATA3 and ETS2 (and possibly STAT3
too) (7). Although experimentally characterized TRMs
are very informative as to the co-activators that key TFs
need to associate with to perform their biological func-
tions, these TRM models have not yet been able to
provide an explanation for how pleiotropic TFs bring
about functional specificity in distinct cell types.
Examples for the pleiotropic functions of TFs are
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as follows: (i) the ESC factor SOX2 is also active in neural
progenitor cells (8), (ii) the essential hematopoietic factor
SCL/TAL1 is also robustly expressed in neural progenitor
cells, (iii) the B-cell development factor FOXO1 is known
to regulate adipocyte differentiation (9) and (iv) the troph-
ectoderm stem-cell factor GATA3 is crucial at various
stages of CD4+ T-cell development (10).
Therefore, a fundamental question in transcriptional
regulation is how a given TF can perform highly divergent
and at the same time crucial functions across distinct cell
types (11). To address this problem, we set out to investi-
gate the mechanisms that enable STAT3 to regulate dis-
tinctive gene sets leading to diverse biological outcomes in
various cell types. STAT3 has been profiled by ChIP-seq
in multiple cell types, including ESCs (4), CD4+ T cells
(12,13), macrophages (14) and AtT-20 corticotroph cells
(15). Crucially, for the dissection of cell type-specific func-
tions, STAT3 has radically different roles in each one of
these cell types: in ESCs, STAT3 maintains pluripotency
(16), whereas in CD4+T cells STAT3 drives the differen-
tiation toward Th17 cells (13,17) and is also required for
Th2 cells (18). In macrophages, STAT3 is essential for the
initiation of the anti-inflammatory response mediated by
IL-10 (19,20), and in AtT-20 corticotroph cells, STAT3
promotes adrenocorticotropic hormone production as
part of the hypothalamo–pituitary–adrenal axis in
response to stress and inflammation (15,21). Clearly,
these diverse functions imply that STAT3 is able to
target different enhancers to regulate distinct genes de-
pending on the biological context. Other advantages of
using STAT3 as a model to investigate TF functional spe-
cificity in the four distinct cellular types described earlier
are as follows: (i) STAT3 is an essential regulator in these
cell types and cannot be replaced by other factors;
(ii) STAT3 is activated upon induction by a cytokine
and thus constitutes a natural switch that produces
easily distinguishable outcomes and (iii) upon activation,
STAT3 initiates a measurable response that is either a
developmental program or a response to an environmental
stimulus.
Here, we analyze genome-wide STAT3 binding data
from ChIP-seq libraries profiled in ESCs, CD4+ T cells,
macrophages and AtT-20 cells and show that STAT3 has
two modes of binding: (i) a small number of
STAT3-binding sites that are common to all four cell
types analyzed which regulate a core set of genes that
are pre-bound by E2F1 and which encode a
self-regulatory loop for STAT3 and (ii) the larger sets of
STAT3-binding events that are cell type-specific and there-
fore responsible for the distinct biological outcomes of
STAT3 in the various cell types. Moreover, by integrating
data on predicted TF-binding sites, protein–protein inter-
actions and gene expression, we built TRM models that
predict the unique associations of STAT3 with distinct sets
of co-factors and which explain how STAT3 directs both
its cell type-independent and cell type-specific functions.
This is the first example of a TF having both cell type-
independent and cell type-specific functions mediated by
distinct TRMs, a modus operandi that might be shared by
other pleiotropic TFs.
MATERIALS AND METHODS
ChIP-seq read mapping and peak calling
ChIP-seq reads were mapped to the mouse genome (mm9)
using Bowtie (v0.12.7) (22) with the setting ‘best’ and with
reads mapping to more than one genomic location being
excluded (m). Peak discovery was performed using
MACS (v1.4.1) (23) using the parameters band-
width=200 and genomesize=mm. The m-fold param-
eter was adjusted until MACS could find 1000–2500
high-quality peaks to construct a model. The P-value for
each ChIP-seq library was determined by increasing the
P-value from 1 1010 until the number of peaks dis-
covered by chance alone (false positives) was close to
1% or the P-value reached 1 105. Detailed genome
mapping statistics and the full list of settings used by
MACS for all of the ChIP-seq data used in this article
are described in Supplementary Table S1.
Gene Ontology (GO) on the ChIP-seq lists was done
using GREAT (v2.0.1) (24) using the whole genome as a
background. Statistical analysis was performed using
SciPy and data visualization used matplotlib, pycairo, R
and glbase (https://bitbucket.org/oaxiom/glbase/wiki/
Home/). For evolutionary conservation analysis, all
pre-computed phastCons scores were obtained from the
UCSC genome browser.
The random backgrounds used for motif enrichment
analysis or for comparison were generated by randomly
sampling 1 or 10% of the appropriate control ChIP-seq
library. Sequence libraries were made unique, allowing
only a single read per genomic position prior to sampling
random sites. This removed repeats that typically attract a
large number of sequence tags and give spurious regions of
overlap. For the ‘shared overlap’, ‘any two cell types’ and
‘any three cell types’, the backgrounds were combined in
equal proportions relative to the size of the contribution of
the cell-type STAT3 binding to the overlap.
Gene expression data
Expression profiles were obtained from the Gene Expres-
sion Omnibus for ESCs (GSE27708) (25), IL-21-treated
anti-CD3/CD28-activated-CD4+ T cells (GSE19198)
(12), IL-6-treated anti-CD3/CD28-activated-naive CD4+
T cells (GSE21671) (13), IL-10-treated peritoneal
exudate cells macrophages (GSE31531) (14), IL-6-treated
liver cells (GSE21060) (26) and AtT-20 cells (GSE19042)
(21). For ESCs, AtT-20 and CD4+T cells, raw data were
processed using the BrainArray custom CDFs (27), while
the RNA-seq macrophage data for PEC macrophage
RNA-seq, transcripts were quantified using RSEM (28)
and annotated to Ensembl genes (release 66).
Motif discovery and identification of TRMs
HOMER (v3.6) (29) was used for de novo motif discovery
with default parameters, with ±200 bp around the peak
summits of the list of STAT3 binding peaks and a random
background sampling of 1% of the appropriate control
ChIP-seq library. TRMs were identified by integrating
motif enrichment, gene expression and protein–protein
interaction information. De novo motifs discovered by
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HOMER that did not resemble STAT3 or a STAT3
half-site were searched again for enrichment using
FIMO (30) to remove motifs with a z-score< 5.0 in all
STAT3 binding lists. De novo motifs detected by
HOMER were annotated with Tomtom (MEME suite)
(matching motifs with a q< 0.05 were kept) (31) using a
library of motifs obtained from the JASPAR and
UniPROBE databases (32,33). Known motifs were
mapped to human genes and pairwise similarities among
motifs were computed with Tomtom to determine clusters
of TFs with similar binding preferences. The original gene
annotations for the motifs were mapped to the human
homologs using the Biomart tool from Ensembl. These
mapped genes were filtered by expression in the appropri-
ate cell type to reduce redundancy. Based on the distribu-
tion of intensities, genes were considered not expressed if
the normalized intensity value was <5.2 for ESCs, <4.1 in
CD4+T cells or <3.9 in AtT-20 cells. For the macrophage
RNA-seq data, those transcripts with a transcripts-
per-million value <1.0 were disregarded. The human
protein–protein interaction network was obtained from
the BioGRID database (34) and nodes were removed for
non-expressed genes in each of the data sets. Additionally,
the nodes UBC and SUMO2 were also removed as they
connect to 60 and 8% of the entire interactome, respect-
ively. Full details on our method for reconstructing TRMs
will be published elsewhere.
ChIP-qPCR of STAT3-bound sites in macrophages
PEC macrophages were purified from pooled 6- to 8-
week-old male C57Bl6JcL mice (CLEA Japan) and
treated with IL-10 (R&D Systems). Formaldehyde
cross-linked chromatin was extracted and subjected to
ChIP using antibodies to STAT3 (SantaCruz, sc-482),
E2F1 (Millipore, 05-379) and GFP (Santa Cruz,
sc-8334), as previously described (14). qPCR was per-
formed on an ABI 7900, using SYBR qPCR mix
(TOYOBO) according to the manufacturer’s instructions.
Primers used in this study are described in Supplementary
Table S2.
RESULTS
A catalogue of STAT3 genomic binding sites in ESCs,
CD4+ T cells, macrophages and AtT-20 cells
To date, the genome-wide binding pattern of STAT3 has
been reported by ChIP-seq in ESCs (4), CD4+T cells (12),
Th17 cells (13), macrophages (14) and AtT-20 corti-
cotroph cells (15). Although each publication provides
an alignment to the genome and a set of characterized
peaks, these were performed at different times where the
sequencing reads were aligned to different mouse genome
assemblies (mm8 and mm9), using various software tools
(ELAND, AceView and bowtie) and a variety of peak
discovery algorithms (MACS, ChIPseq and AceView).
In order to compare the various ChIP-seq libraries,
these and their corresponding control libraries (raw
sequence reads) were uniformly reanalyzed, except for
the STAT3 ChIP-seq library prepared in Th17 cells as it
lacks a paired control library (13). Nevertheless CD4+ T
cells contain small numbers of Th17 cells, meaning that
the CD4+ T-cell ChIP-seq library will contain many
Th17-specific STAT3-binding sites. For each cell type,
ChIP-seq library replicates were merged into a single
fastq file and bowtie (22) was used to align the reads to
the mm9 version of the mouse genome. The peak discov-
ery tool used was MACS (23), which reports the number
of peaks discovered by chance alone by reversing the ex-
perimental and control libraries. At the default cutoff
(P=1 105), MACS has a tendency to inflate the
number of peaks reported for larger sequence libraries at
the expense of increasing the number of false positives. To
correct for this bias, we adjusted the MACS P-value cutoff
to limit the number of peaks discovered by chance alone
(false positives) to 1% (Supplementary Figure S1 and
Supplementary Table S1). Thus, we report 2651 (ESCs),
5152 (CD4+ T cells), 1724 (macrophages) and 7982
(AtT-20) peaks. Of the original sets of peaks defined in
the respective publications, our new peak lists contain
66% of the ESCs peaks, 81% of the CD4+ T-cell peaks,
87% of the macrophage peaks and 100% of the AtT-20
peaks. Although the majority of the peaks that were
missed are lower ranked peaks (Supplementary Figure
S2), we also report new additional peaks in CD4+ T
cells (756), ESCs (245), macrophages (372) and AtT-20
cells (4881). Similarly, most of these new peaks are
lower ranked peaks by fold enrichment of the experimen-
tal libraries over the control libraries (Supplementary
Figure S2).
STAT3 regulates a core set of genes across all four
cellular types
STAT3 peaks were defined by extending the summits
determined by MACS 200 bp either side of each summit,
and overlapping peaks were merged by taking the mid-
point between the two summits. Whenever peaks overlap-
ped, they tended to be close (Figure 1A) and only 35 peaks
were found to be common to all four libraries (Figure 1B).
These 35 peaks overlapping across all four libraries were
highly ranked STAT3-binding sites, with one-half of these
35 overlapping peaks being listed in the top 1000 STAT3
peaks in all four libraries (Figure 1C). Moreover, a Monte
Carlo simulation of the overlap suggested that the number
of overlapping peaks that would be expected among all
four libraries by chance alone is zero (expected
overlapping sites: 0.002±0.045) (Figure 1B). Therefore,
the 35 STAT3-binding events shared by all four ChIP-seq
libraries are not random, while most STAT3-binding
events are highly specific to each cell type (Supplementary
Figures S3 and S4; Supplementary Table S3). Conser-
vation of transcriptional regulation can also be
gene-centric, where regulatory TF-binding sites do not
overlap but still regulate the same nearby gene. This has
been reported for SMAD3 (35) and during evolution for
CEBPA (36). However, we did not find robust evidence
for systematic gene-centric regulation as the number of
gene-centric observations was close to the values
expected by chance alone (Supplementary Figure S5).
The distribution of STAT3-binding events relative to
gene locations is typical of other TF ChIP-seq libraries,













Figure 1. STAT3 binds to a small but significant ‘shared overlap’ of binding sites in divergent cell types, but is otherwise strongly cell type specific.
(A) Summary of the distances between the overlapping peaks for each pair of STAT3 ChIP-seq libraries. The distance was measured as the number
of base pairs between the summits of the two overlapping peaks. (B) Overlap of the binding peaks in three STAT3 libraries culled from mouse ESCs,
CD4+T cells, macrophages and AtT-20 cells. Peaks were considered to overlap if their peak summits were within 200 bp of one another. The overlap
was simulated by generating lists of faux ChIP-seq peaks followed by the assessment of their overlap (this was performed 1000 times to generate the
number of overlaps expected by chance-value listed in brackets). (C) The ‘shared overlap’ sites are more likely found in the most highly ranked
STAT3-binding sites. STAT3-binding sites were ranked by fold enrichment and then the cumulative overlap of STAT3 peaks appearing in all four
cell types was plotted for ESCs, CD4+ T cells, macrophages and AtT-20 cells. (D) Genome distributions of STAT3-binding sites orientated with
respect to the nearest gene to the STAT3-binding site. Coloured bars describe the distance from the STAT3-binding sites to the nearest TSS, as
described in the key. The gray regions denote a random background and represent the expected distribution of peaks were the binding sites randomly
distributed across the sequenceable genome.
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with one-third of STAT3 peaks located within 10 kb of the
nearest TSS (Figure 1D and Supplementary Table S4).
However, the ‘shared overlap’ of 35 STAT3-binding
events across all four cellular types has a very strong
bias toward the TSS, with 30 of 35 (86%) STAT3
peaks being located within 10 kb of the TSS. As proximity
to the TSS has been linked with the control of gene ex-
pression (4,37), this suggests that the 35 STAT3 peaks
likely regulate the expression of the genes they lie closest
to. Many of these genes are essential for STAT3 function,
including Stat3 itself, Socs3, Bcl3 and Ptpn1 (Figure 2A).
Not surprisingly the shared 35 STAT3-binding events
show a much greater degree of evolutionary conservation
than any set of cell type-specific STAT3 peaks (Figure 2B).
Most of the 35 STAT3-binding events shared across all
four cellular types are located within 10 kb of a TSS,
although the assignment between TF-binding events and
gene regulation is still an open question as no generally
applicable model has yet been described. The association
by proximity of TF-binding events with the genes nearby
shows that typically only 10–20% of such genes are dif-
ferentially expressed (10,14,38). To investigate the effects
of the 35 STAT3-binding events on the expression of the
closest genes, we analyzed expression data for the four
cellular types analyzed here plus two additional conditions
where STAT3 is also activated by a cytokine: naive CD4+
T cells stimulated by IL-6 (13) and liver cells stimulated by
IL-6 (for which the STAT3 genome-wide binding profile is
not known) (26). Gene expression values of the
cytokine-stimulated cells were combined and ranked by
fold-change relative to controls, while the expression
data from ESCs were inverted (as the withdrawal of LIF
causes ESCs to differentiate). Remarkably, about one-half
of the genes are up-regulated upon cytokine stimulation in
all six conditions (Figure 3B) and strikingly only a few
genes are down-regulated. This indicates that a core unit
of STAT3 regulation occurs in all these biological contexts
and cellular types, including the well-characterized targets
of STAT3, Socs3 and Bcl3, which are up-regulated in all
six conditions.
The 35 STAT3-binding events common to all four cell
types regulate a diverse set of genes involved in the main-
tenance of specific cellular activities. GO analysis using
GREAT (24) reported an over-representation of signal
transduction pathways related to STAT3 (Figure 3A).
The promoters of Stat3 and Stat1 are both bound and
induced by the recruitment of STAT3 in all four cell
types (Figure 3B). Moreover, it is remarkable to find
that three genes involved in three different pathways
that negatively regulate JAK-STAT signaling are
induced by STAT3, suggesting that STAT3 is acting to
regulate its own activity. These include PTP1B (Ptpn1),
a protein tyrosine phosphatase reported to dephospho-
rylate JAK2 and TYK2 and also phospho-STAT3 (39).
Additionally, SOCS3 is part of the ubiquitin pathway
that negatively regulates JAK-STAT signaling by
degrading both JAKs and STATs (40). A third mechanism
of negative feedback is the suppressive function of the
RNA-binding protein Zfp36 (Tristetraprolin) which nega-
tively regulates IL-10 signaling in macrophages (41).
Zfp36 could thus be playing an identical role in all four
cell types described here. The remaining genes include over
a dozen TFs, such as Stat3, Stat1, Bcl3, Bcl6, Tcf4, Cic,
Sbno1 and the AP-1 family members Fos and Junb
(GO:0003676: ‘nucleic acid binding’, GREAT FDR
q=3.6 102), which deserve further characterization.
In addition to these, our STAT3 target set comprises
several genes encoding proteins involved in DNA replica-
tion and repair, protein translation, cytoskeletal reorgan-
ization and protein trafficking and notably six genes that
encode proteins involved in metabolism (summarized in
Supplementary Table S5). Our findings on the STAT3
transcriptional program common to all four cellular
types indicate that STAT3 establishes its own regulatory
network by the following: (i) perpetuating its own tran-
scription, (ii) being a master regulator of other TFs
working downstream of it, (iii) stimulating the transcrip-
tion of cytoplasmic enzymes that control STAT3’s activity
and (iv) ensuring an efficient and robust cellular division
program and the maintenance of a stable cell type. The
STAT3 transcriptional program involves many levels of
cellular control from basic DNA replication and chroma-
tin remodeling, to the cell metabolic pathways producing
key metabolites needed for increasing the transcriptional
and translational processes essential in cell division and
maintenance.
A distinct TRM defines cell type-independent STAT3
binding across all four cellular types
Since STAT3 binds to 35 identical sites across four distinct
cellular types, it is reasonable to assume that it does so by
assembling around a TRM that is common to all cellular
types. To reconstruct the putative TRM that directs the
expression of the genes regulated by the 35 STAT3-
binding events, we integrated over-represented TF-
binding sites co-occurring with STAT3-binding sites,
protein–protein interaction data and expression data
(as detailed in the ‘Materials and Methods’ section). The
resulting TRM (Figure 4A and Supplementary Figure S6)
is unique to the 35 STAT3-binding events shared by all
cellular types and contains a number of co-factors and
other proteins that are known to bind to STAT3 experi-
mentally and whose corresponding genes are expressed in
all four cellular types. The co-TFs that appear to work
together with STAT3 in this TRM include many ‘general’
TFs known to operate in a variety of biological contexts.
The cell type-independent TRM contains the TFs MYC,
E2F1 and KLF4, all of which have been profiled by
ChIP-seq in ESCs (4). These ChIP-seq libraries were
re-analyzed as before (full details included in Supple-
mentary Table S1) and we determined the co-occupancy
of the 35 STAT3-binding events by MYC, E2F1 and
KLF4 in ESCs. We found that 34 of 35 (97%) of the
STAT3 peaks are co-occupied (within 800 bp of each
other) by n-MYC, E2F1 or KLF4 and often by several
of them (Figure 4B and Supplementary Figure S7), but
only 19 of 35 (54%) are co-occupied by one of the ESC-
specific factors ESRRB, SOX2, OCT4 or NANOG
(Figure 4B). It must be noted that co-occupancy is not a
factor of the number of peaks of the ChIP-seq libraries as
ESRRB has the largest number of peaks (56 136) as
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A
B
Figure 2. The shared overlap of STAT3-binding sites controls the expression of a core set of genes important for STAT3 function. (A) Genomic
views of STAT3 ChIP-seq sequence tag densities for four STAT3-binding sites common to ESCs, CD4+ T cells, macrophages and AtT-20 cells.
STAT3 binding is shown around the TSS of Stat3 and Socs3, within the second intron of Bcl3 and 6 kb 50 of the TSS of Ptpn1. (B) Average
evolutionary conservation for the different categories of STAT3-binding events. STAT3 peak summits were extended by 1 kb either side
and the Euarchontoglires evolutionary conservation scores were annotated as determined by phastCons in the UCSC Genome Browser
(http://genome.ucsc.edu/).
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opposed to E2F1 (11 448 peaks) (Supplementary Table
S1). Finally, for a limited number of STAT3-binding
sites in the shared overlap, we also probed their occupancy
in IL-10 treated macrophages by ChIP-qPCR (Figure 4C).
As expected, STAT3 is specifically recruited to all of the
14 sites we probed by ChIP-qPCR and remarkably E2F1
is not only bound at these same sites but is actually
pre-bound at these sites close to STAT3 binding (with
the exception of Diap1, Figure 4C). STAT3 is therefore
specifically recruited to genomic loci that already have
E2F1 bound. This may explain why several of these
genes show very rapid induction of expression upon stimu-
lation with IL-10 (14,42) since they are poised for expres-
sion by the presence of E2F1. In summary, STAT3
appears to use a TRM, binding close to E2F1 and
possibly MYC, to regulate a core set of genes that tune
the JAK-STAT pathway and to promote cell proliferation
while counteracting differentiation.
Cell type-specific binding events determine the various
functions of STAT3 in ESCs, CD4+ T cells, macrophages
and AtT-20 cells
Since the 35 STAT3-binding events shared across all four
cell types encode a self-regulatory program for STAT3
that is cell type-independent, the cell type-specific
STAT3-binding events should be related to the specific
functions of STAT3 in each of the four distinct cell
types. GO analysis of the cell type-specific STAT3-
binding events using the ‘Biological Process’ category
shows that the most over-represented terms in ESCs
include distinctive ESC functions such as ‘stem-cell main-
tenance’ and ‘stem-cell differentiation’ (Figure 5A).
A
B
Figure 3. The shared overlap STAT3-binding sites co-regulate a set of key genes important for STAT3 function in multiple cell types.
(A) Significantly over-represented terms from the ‘Pathway Commons’ category for the genes associated with the shared overlap. Shown here are
the top five terms only. A significant q-value of 0.05 is represented by a solid black line and a q-value of 0.01 by a dotted gray line. (B) The
expression of the closest genes within 200 kb of the shared overlap was measured in a series of gene expression microarray data sets which show the
activation of STAT3 or the loss of STAT3 activity (LIF withdrawal from ESCs). Expression data are reversed in ESCs for clarity, but is otherwise
down-regulated upon removal of LIF whereas all other treatments show up-regulation in response to cytokine stimulation. P-values are from a
Wilcoxon test between the treated and untreated conditions: CD4+ T cells treated with IL-21 (P=5.59 105) (GSE19198), naı̈ve CD4+ T cells
treated with IL-6 (P=2.45 103) (GSE21671), ESCs upon withdrawal of LIF from the medium (P=0.027) (GSE27708), peritoneal macrophages
stimulated with IL-10 (P=2.14 104) (GSE31529), AtT-20 cells treated with LIF (P=1.00 104) (GSE19042) and liver cells stimulated with IL-6
(P=0.032) (GSE21060). Genes marked in green do not have a corresponding probe on the microarray.












Figure 4. The shared overlap of STAT3 binding in all four cell types forms a cell type-independent regulatory network with MYC and E2F1.
(A) HOMER was used to generate de novo motifs from the list of 35 STAT3-binding sites common to all four cell types. Motifs resembling STAT3
or a STAT3 half-site were removed and over-represented motifs were collected and annotated to genes. Interaction networks were constructed by
interrogating the PPI network for proteins interacting with those representing the enriched motifs. TFs were clustered together by motif similarity
and coloured by the cluster they belong to: white-colored nodes do not have a representative motif in the databases or do not bind to DNA directly;
proteins with a bold circle have a motif enriched in that cell type, while proteins with no bolded circle have no discovered motif but were linked to
STAT3 through the PPI network. Proteins in the network were filtered by gene expression and here we present the union of the network in all four
cell types (the separate networks are presented in Supplementary Figure S6) (B) ChIP-seq data from ESCs (GSE11431) were re-analyzed and binding
sites overlapping within 400 bp were collected. The heatmap shows the 35 STAT3-binding sites together with the other TFs bound in the vicinity of
STAT3. (C) We designed primers for 14 STAT3-binding sites shared between all four cell types and performed ChIP-qPCR. Macrophages were
treated for 4 h with IL-10 (black bars) or left untreated (white bars) and chromatin was harvested. ChIP was performed using antibodies against
STAT3 (left panel), E2F1 (right panel) or GFP (as a control in both panels). Each group of bars represents a STAT3-binding site and is labeled with
the name of the nearest gene.
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Likewise, in CD4+T cells and macrophages terms pertain-
ing to relevant processes were recovered. For AtT-20 cells,
as a pituitary epithelial cell line, there are several terms
related to epithelial cell function, including ‘cell–cell
junction organization’, ‘cellular response to radiation’,
‘plasma membrane organization’ and particularly ‘regula-
tion of insulin receptor signaling pathway’, indicating the
role that the pituitary plays in responding to insulin. The
over-represented terms from the Mouse Genome
Database genotypes::phenotypes (43) are also indicative
of specific STAT3 functions in the four cellular types,
including ‘abnormal cytokine secretion’ (macrophages),
‘abnormal adaptive immunity’ (CD4+ T cells), ‘complete
embryonic lethality’ (ESCs) and ‘increased body
A
B
Figure 5. STAT3 biological specificity is found within the cell type-specific lists of genomic binding sites. Gene Ontology term enrichment analysis
was done using GREAT with default parameters. Over-represented terms displayed here are from the ‘Biological Process’ category (A) and the
Mouse genome informatics phenotype::genotype category (B). A significant q-value of 0.05 is represented by a solid black line and a q-value of 0.01
by a dotted gray line.
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temperature’ (AtT-20 cells, since one of the functions of
the pituitary is to regulate body temperature) (Figure 5B).
Collectively, the GO analyses of the cell type-specific
STAT3-binding events suggest that the functional specifi-
city of STAT3 in each cell type is contained within the cell
type-specific lists of STAT3-binding events and not within
the shared overlap of peaks common to all four cellular
types, which as we have previously shown has diverse cell
type-independent functions.
Non-canonical DNA binding is prevalent across distinct
cellular types but is not sufficient to explain STAT3’s
divergent functions
The DNA binding preferences for paralogous classes of
TF tend to be rather uniform, making it difficult to attri-
bute biological specificity to DNA base changes in TF-
binding motifs. A clear example is provided by
homeodomain TFs, all of which have strikingly similar
DNA binding preferences despite encompassing all of
mammalian development (2). The case of STAT3 is par-
ticular because although STAT3 has a well-defined canon-
ical motif (TTCnnnGAA), it has nevertheless been
reported to use a unique variant motif (TTAnnnGAA)
to regulate the Prdm1 gene in CD4+ T cells (12).
The general motif recovered de novo in each set of cell
type-specific STAT3-binding events is the prototypical
STAT3 motif (Figure 6A), which is shared by other
STAT factors too (44). Since alternative motifs appear
to be important for STAT3 function, we investigated the
presence of all possible STAT3 motif variants in the set of
STAT3 peaks in each cellular type. This was done by
counting STAT3 motifs where single base pairs were indi-
vidually mutated and z-scores were derived by comparing
against randomly selected sets of background sites drawn
from the respective ChIP-seq control libraries.
As expected, the STAT3 canonical binding site was
found in all four cellular types and the shared overlap
(Figure 6B). The variant TTAnnnGAA previously
characterized in CD4+ T cells (12) was over-represented
not only in CD4+T cells but also in ESCs and AtT-20 cells
(but not in macrophages). The variant STAT3 motif
TGCnnnGAA is over-represented in all four cellular
types, suggesting that this is a common alternative mode
of DNA binding by STAT3. Finally, the motif
CTCnnnGAA appears to be a variant used by STAT3
exclusively in AtT-20 cells (Figure 6B).
Moreover, we quantified the usage of the various ca-
nonical and variant motifs for each set of STAT3 peaks
(Figure 6C). All STAT3 peaks contain putative half-sites
(TTCC), often several of them per peak. At most 28% of
STAT3 peaks harbor a perfect canonical site (in ESCs)
while non-canonical sites are especially prevalent in
AtT-20 cells (48% of sites). The set of 35 STAT3-
binding events shared by all four cellular types turned
out to be especially conservative in the use of canonical
motifs, with 43% containing a canonical STAT3 motif.
The binding of STAT3 to variant motifs could be linked
to specific functions: for instance, the binding of STAT3
to canonical TTCnnnGAA might facilitate the recruit-
ment of generic co-activators, such as p300, whereas the
binding to the variant motif TTAnnnGAA (as is the case
in CD4+ T cells) might lead to the recruitment of specific
regulatory complexes. The differential recruitment of
co-activators could be allosterically induced by different
DNA ligands, as demonstrated for the glucocorticoid
receptor (45), a model that provides a conceptual frame-
work for understanding the functional plasticity of pleio-
tropic TFs such as STAT3. Here, the binding of STAT3 to
variant DNA motifs induces conformational changes on
the binding proteins, which in turn affect the recruitment
of co-activators. Indeed, in the case of STAT3, specific
base pairs that vary between the canonical and the
variant motifs TTAnnnGAA and TGCnnnGAA (i.e.
T[TC] versus T[TA] or T[GC]) are directly contacted by
Asn466 of the connector domain of STAT3, in which case
Asn466 must structurally rearrange to accommodate the
altered chemical environment introduced by these variant
motifs (Figure 6D) (46). These structural rearrangements
could translate into global structural changes to the con-
nector domain as well as the neighboring and C-terminal
SH2 domain that mediates interactions with other
proteins by recognizing phosphotyrosine residues.
A further effect of specific variant motifs and specific
co-factor interactions might be the stabilization of the
TRM and the tethering of STAT3 to DNA. Indeed,
Husby et al. (47) recently proposed that the two halves
of the STAT3 homodimer do not make identical base pair
contacts on a TTAGnGGAA variant motif. We found no
clear link between the presence of variant motifs and
specific biological functions, although there were several
prominent examples including the aforementioned Prdm1,
Il17a and Il17ra (both of which have nearby STAT3-
binding sites with the variant motif TTAnnnGAA) and
Cd28, which is associated with the STAT3 variant motif
TGCtggGAA. The presence of alternative STAT3-binding
motifs highlights the usage of variant motifs in regulating
specific genes, although no clear pattern that explains how
variant motifs encode the cell type-specific functions of
STAT3 could be discerned.
Distinct TRMs determine STAT3’s cell type-specific
functions
In the absence of a clear contribution by variant DNA
motifs to explain STAT3’s cell type-specific functions, an
attractive model providing biological specificity is one
where various factors cluster together in a cooperative
manner to provide biological specificity (48). This
‘piling-up’ of TFs and co-factors has been demonstrated
by ChIP-seq experiments in ESCs, B cells and blood stem-
cell precursors (4,5,29). One limitation of this approach,
however, is that the identities of biologically relevant TFs
need to be known in advance before performing any
ChIP-seq experiment that will eventually allow one to re-
construct a transcriptional regulatory network (49).
By employing the same data integration and analysis
techniques that we used to reconstruct the cell type-
independent TRM regulating the shared overlap of 35
STAT3-binding events (Figure 4A), we generated models
for the cell type-specific binding events of STAT3 in
ESCs, CD4+ T cells, macrophages and AtT-20 cells
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(Figure 7A–D). We managed to recover the well-
characterized ESC transcriptional regulatory network (4)
comprising OCT4 (represented here by the motif
POU2F2), SOX2, ESRRB, KLF4 and SMAD1 and a
number of homeodomain proteins that may correspond
to NANOG (Figure 7A). In addition, we identified
TEAD1, a protein recently shown to be essential to
maintain ESC pluripotency (50) and also identified in
human ESCs as a potential key TF (51), and REST,
whose role is to repress specific genes in ESCs and so
block differentiation (52). This network is reminiscent of





Figure 6. STAT3 uses alternative (non-canonical) modes of binding to DNA. (A) de novo generated motifs from HOMER are very similar in the six
lists of STAT3 binding. Motifs were generated from the entire lists of STAT3-binding sites for each category, except for CD4+ T cells where the top
1000 sites were used (as for the entire list we could only identify a STAT3 half-site). (B) z-score heatmap to show over representation of variant
STAT3 motifs in the STAT3-binding sites in the various cell types. Variant motifs are presented here as all single base pair mutations of one-half of
the STAT3 heterodimeric motif. (C) Pie charts showing the frequency of the DNA words TTCnnnGAA (canonical STAT3) or a non-canonical
STAT3 binding: TTAnnnGGA and TGCnnnGGA for ESCs, CD4+ T cells, any two cell types and any three cell types; TGCnnnGAA for macro-
phages and the shared overlap; and TTAnnnGGA, TGCnnnGGA and CTCnnnGAA for AtT-20 cells. (D) Cartoon representation of the Asn466
amino acid of STAT3 making contact with the DNA base pairs [PDB entry 1bg1 (46)].














Figure 7. Discrete transcriptional regulatory modules (TRM) determine STAT3 cell type-specific functions. TRMs for each cell type were generated
by collecting de novo motifs generated by HOMER and excluding motifs resembling STAT3 or a STAT3 half-site. Motifs were then scanned again
and compared to a random background generated from the control background libraries to generate a z-score. Motifs with a z-score< 5.0 were
removed and finally motifs were annotated to genes. These genes were filtered by expression data derived from the appropriate cell type and
interaction networks were constructed by interrogating the PPI space. TFs were clustered together by motif similarity and coloured by the
cluster they belong to. Proteins with a bold circle have an motif enriched in that particular cell type, while proteins without a bold circle have
no enriched motif but were linked to STAT3 through the PPI network. White-coloured nodes do not have a representative motif in the motif
databases or do not bind to DNA directly. The networks are divided into the cell type-specific lists for ESCs (A), CD4+ T cells (B), macrophages
(C) and AtT-20 cells (D). (E) Pairwise correlation heatmap of the ChIP-seq peaks from ESCs, CD4+ T cells and the STAT3-binding sites described
here. The lists of peaks were assessed for overlap in an all-against-all comparison and Pearson correlation scores were used to measured the
frequencies of overlapping peaks when compared to all other overlaps.
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(53,54), although it is only a partial match possibly
because STAT3 was not used as a bait in the generation
of those networks.
The transcriptional regulatory network of CD4+T cells
is much less well characterized, but we managed to
identify the only known STAT3-binding partner in the
CD4+ T cells, IRF4 (12) (Figure 6B). Our model of the
TRM of CD4+T cells is completed by members of the TF
families AP-1, several ETS-related TFs that are known to
play important roles in T-cell biology (55) and a diversity
of other TFs. ATF1 is recruited to the Ifng promoter in
CD4+T cells and with CREB represses Ifng expression in
naive CD4+ T cells (56). Tantalizingly, STAT3 is also
bound at the Ifng promoter and may co-operate with
ATF1 to regulate Ifng expression. Finally, we also
identify multiple GATA factors associated with STAT3
(Figure 7B), of which GATA3 is known to have
multiple roles in T-cell development (10).
In macrophages, several classes of TF were identified
(Figure 7C), the most important of which are members
of the AP-1 family (FOS, NFE2L2 and JUN), where
STAT3 might in turn be regulating the expression of
FOS and NFE2L2 as it binds very close to their TSS
and CEBPA, which is known to reprogram pre-B cells
into macrophages (57).
The STAT3 transcriptional regulatory network of
AtT-20 cells is less well characterized than those of
ESCs and CD4+ T cells, and our TRM model suggests
many potential partners for STAT3 in AtT-20 cells
(Figure 7D). We did not recover any motif matching the
glucocorticoid receptor-binding site, which although it is
linked to the function of STAT3 in AtT-20 cells, it
co-localizes with STAT3 in only 21% of STAT3-binding
sites, of which 50% require the presence of glucocortic-
oid to co-recruit GR and STAT3 (15).
Finally, a pairwise correlation among the TF-specific
binding events derived from ChIP-seq libraries done in
ESCs, and all of the STAT3-binding events derived
likewise (across all four cellular types) show the distinct
TRMs characteristic of ESCs and T cells (Figure 7E).
These TRMs contain both the previously reported TRM
specific to ESCs (OCT4, SOX2, ESRRB and NANOG)
and the ‘MYC-regulated’ block (MYC, E2F1).
Additionally, a new TRM consisting of STAT3, IRF4
and a more loosely associated GATA3 emerged in
various T-cell subsets. STAT3 binding in macrophages
and AtT-20 cells have no other partner TFs from the pub-
lished ChIP-seq libraries and hence form isolated clusters.
These results demonstrate that STAT3 forms distinct cell
type-specific TRMs to execute a diversity of gene expres-
sion programs.
DISCUSSION
In this study, we have investigated the factors that deter-
mine the functions of STAT3 in various cell types. STAT3
binding is predominantly cell type-specific, with just a
small but significant number (35) of binding sites shared
among ESCs, CD4+ T cells, macrophages and AtT-20
cells. This shared overlap appears to be a mode of
auto-regulation for STAT3 function and targets many
genes that are all directly up-regulated by STAT3
binding. Additionally, STAT3 also co-binds with E2F1,
which is present at the same STAT3-binding sites in at
least ESCs and macrophages, and we demonstrate that
at least in macrophages E2F1 is even pre-bound to the
future STAT3-binding sites. This may explain why so
many of these STAT3-regulated genes are rapidly
induced in <1 h upon stimulation with a cytokine. The
recruitment of STAT3 to DNA via variant motifs does
not appear to be a major factor regulating STAT3’s func-
tions across diverse cell types. Nevertheless, a more plaus-
ible explanation is provided by the assembly of distinct
TRMs around STAT3 in the four cell types. We
produced models of TRMs by integrating TF-binding
site data, protein–protein interaction and expression
data that provide an explanation for STAT3’s specific bio-
logical functions across distinct cell types. Using just the
STAT3-binding events in ESCs, we succeeded in recover-
ing the ESCs-regulatory network and also propose
STAT3-based TRMs for CD4+ T cells, macrophages
and AtT-20 cells.
The cell type-specific TRM models of STAT3 predict an
important level of epigenetic regulation, as these contain
many histone-modifying enzymes, several histone deace-
tylases (HDAC2, HDAC3) histone acetyltransferases
(EP300) and remodeling enzymes (SMARCE1,
SMARCA4, SMARCC1) (Figure 7A–D). Additionally,
in human ESCs, SIN3A, EP300 and HDAC2 are known
to be associated with the ESC regulatory network (51), of
which we identified SIN3A and EP300 (Figure 7A).
SIN3A has been proposed as a master regulator of
STAT activity, particularly in guiding STAT3 to the
Socs3 gene (58). Histone modifications likely play a
major role in determining cell type specificity either by
blocking other STAT3-binding sites from becoming avail-
able or by pre-marking sites that STAT3 can be recruited
to. Vallania et al. (59) computationally predicted 1.3
million STAT3-binding sites in the mouse genome. We
nevertheless know from ChIP-seq experiments that
STAT3 is binding to a fraction of these sites in distinct
cell types. Although other members of the STAT family
that share a very similar DNA-binding motif with STAT3
(44) might actually be occupying these other sites, in our
opinion this possibility does not entirely explain why all
those potential binding sites are unavailable to STAT3.
Therefore, epigenetic regulation is probably a major
factor controlling STAT3 transcriptional programs and
has previously been shown for members of the STAT
family of TFs (17). It remains to be determined whether
chromatin is initially available for STAT3 recruitment,
whether STAT3 binds to inaccessible sites but recruits
chromatin modifiers to locally open the chromatin or a
combination of both.
A number of TFs have been profiled by ChIP-seq in
multiple cell types and a spectrum is emerging that goes
from the exclusively cell type-invariant TFs to other TFs
that are exclusively cell type-specific and a number of TFs
that lie in between these two extremes. Among the
remarkably cell type-invariant TFs is CTCF (60), whose
primary role appears to be in maintaining the architecture
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of the genome. However, CTCF can also act as a typical
cell type-specific TF. REST is another role appears to be
in maintaining the architecture of the genome. REST is
another cell type-independent TF with important roles in
ESCs and neural precursors (52). Among the cell
type-specific TFs are SMAD3, which only shares three
genomic binding sites across mouse ESCs, myotubes and
pro-B cells and only 1% of sites appear in two or more cell
types (35). Additionally, SMAD1 and TCF7L2 show only
a small overlap in binding sites in two different human cell
lines in the erythroid lineage (61) and TCF7L2 similarly to
STAT3 shows only a small overlap in common between
six cells lines (62). MYC lies somewhere in the center of
the specificity spectrum (60), thus reflecting its dual role as
a cell type-specific TF and a ‘global’ regulator of tran-
scription potentially regulating 15% of human genes
(63). Finally, GATA3 binding was explored in multiple
CD4+ T-cell subtypes and shown to be predominantly
cell type-specific even within closely related cells of the
T-cell lineage (10). Therefore, we could say that both
GATA3 and STAT3 are predominantly cell type-specific
although they share a limited number of binding sites that
are common to all cell types where they have been
profiled. These observations place GATA3 and STAT3
between MYC and SMAD1/SMAD3/TCF7L2.
CONCLUSIONS
Our analyses lead us to propose a dual model for STAT3
transcriptional regulation: (i) a limited, cell type-
independent and evolutionarily conserved mode whereby
STAT3 binds to DNA close to (and may co-operate with)
MYC and E2F1 (and possibly other factors too) to
regulate the expression of a set of genes in multiple cell
types that regulate STAT3’s own signaling activity and (ii)
a broader set of cell type-specific binding modes controlled
by distinct cell type-specific TRMs that form around
STAT3 to enact cell type-specific functions (Figure 8).
This dual model of transcriptional regulation by means
of assembling distinct TRMs around a master TF could
be a general mechanism to regulate the transcriptional
programs of other pleiotropic TFs.
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Jeanne and Jean-Louis Lévesque Chair in Cancer
Research and Canadian Cancer Society Research
Institute [#700922 to M.L.T.]. Funding for open access
charge: JSPS.
Conflict of interest statement. None declared.
REFERENCES
1. Badis,G., Berger,M.F., Philippakis,A.A., Talukder,S.,
Gehrke,A.R., Jaeger,S.A., Chan,E.T., Metzler,G., Vedenko,A.,
Chen,X. et al. (2009) Diversity and complexity in DNA
recognition by transcription factors. Science, 324, 1720–1723.
2. Berger,M.F., Badis,G., Gehrke,A.R., Talukder,S.,
Philippakis,A.A., Pena-Castillo,L., Alleyne,T.M., Mnaimneh,S.,
Botvinnik,O.B., Chan,E.T. et al. (2008) Variation in
homeodomain DNA binding revealed by high-resolution analysis
of sequence preferences. Cell, 133, 1266–1276.
Figure 8. A putative model explaining how STAT3 can perform both cell type-independent and cell type-specific functions by assembling around distinct
TRMs. STAT3 binding to the genome occurs in two distinct ways: (i) a cell type-independent mode that is primarily concerned with the regulation of
STAT3’s own activity and (ii) a number of cell type-specific modes that execute distinct transcriptional programmes in various cell types.








ong Kong user on 15 February 2019
3. Arvey,A., Agius,P., Noble,W.S. and Leslie,C. (2012) Sequence
and chromatin determinants of cell-type-specific transcription
factor binding. Genome Res., 22, 1723–1734.
4. Chen,X., Xu,H., Yuan,P., Fang,F., Huss,M., Vega,V.B., Wong,E.,
Orlov,Y.L., Zhang,W., Jiang,J. et al. (2008) Integration of
external signaling pathways with the core transcriptional network
in embryonic stem cells. Cell, 133, 1106–1117.
5. Wilson,N.K., Foster,S.D., Wang,X., Knezevic,K., Schutte,J.,
Kaimakis,P., Chilarska,P.M., Kinston,S., Ouwehand,W.H.,
Dzierzak,E. et al. (2010) Combinatorial transcriptional control in
blood stem/progenitor cells: genome-wide analysis of ten major
transcriptional regulators. Cell Stem Cell, 7, 532–544.
6. Lin,Y.C., Jhunjhunwala,S., Benner,C., Heinz,S., Welinder,E.,
Mansson,R., Sigvardsson,M., Hagman,J., Espinoza,C.A.,
Dutkowski,J. et al. (2010) A global network of transcription
factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell
fate. Nat. Immunol., 11, 635–643.
7. Kidder,B.L. and Palmer,S. (2010) Examination of transcriptional
networks reveals an important role for TCFAP2C, SMARCA4,
and EOMES in trophoblast stem cell maintenance. Genome Res.,
20, 458–472.
8. Graham,V., Khudyakov,J., Ellis,P. and Pevny,L. (2003) SOX2
functions to maintain neural progenitor identity. Neuron, 39,
749–765.
9. Nakae,J., Kitamura,T., Kitamura,Y., Biggs,W.H. 3rd, Arden,K.C.
and Accili,D. (2003) The forkhead transcription factor Foxo1
regulates adipocyte differentiation. Dev. Cell, 4, 119–129.
10. Wei,G., Abraham,B.J., Yagi,R., Jothi,R., Cui,K., Sharma,S.,
Narlikar,L., Northrup,D.L., Tang,Q., Paul,W.E. et al. (2011)
Genome-wide analyses of transcription factor GATA3-
mediated gene regulation in distinct T cell types. Immunity, 35,
299–311.
11. Neph,S., Stergachis,A.B., Reynolds,A., Sandstrom,R.,
Borenstein,E. and Stamatoyannopoulos,J.A. (2012) Circuitry and
dynamics of human transcription factor regulatory networks. Cell,
150, 1274–1286.
12. Kwon,H., Thierry-Mieg,D., Thierry-Mieg,J., Kim,H.P., Oh,J.,
Tunyaplin,C., Carotta,S., Donovan,C.E., Goldman,M.L., Tailor,P.
et al. (2009) Analysis of interleukin-21-induced Prdm1 gene
regulation reveals functional cooperation of STAT3 and IRF4
transcription factors. Immunity, 31, 941–952.
13. Durant,L., Watford,W.T., Ramos,H.L., Laurence,A., Vahedi,G.,
Wei,L., Takahashi,H., Sun,H.W., Kanno,Y., Powrie,F. et al.
(2010) Diverse targets of the transcription factor STAT3
contribute to T cell pathogenicity and homeostasis. Immunity, 32,
605–615.
14. Hutchins,A.P., Poulain,S. and Miranda-Saavedra,D. (2012)
Genome-wide analysis of STAT3 binding in vivo predicts
effectors of the anti-inflammatory response in macrophages.
Blood, 119, e110–e119.
15. Langlais,D., Couture,C., Balsalobre,A. and Drouin,J. (2012) The
Stat3/GR interaction code: predictive value of direct/indirect
DNA recruitment for transcription outcome. Mol. Cell, 47, 38–49.
16. Niwa,H., Burdon,T., Chambers,I. and Smith,A. (1998)
Self-renewal of pluripotent embryonic stem cells is mediated via
activation of STAT3. Genes Dev., 12, 2048–2060.
17. O’Shea,J.J., Lahesmaa,R., Vahedi,G., Laurence,A. and Kanno,Y.
(2011) Genomic views of STAT function in CD4+ T helper cell
differentiation. Nat. Rev. Immunol., 11, 239–250.
18. Stritesky,G.L., Muthukrishnan,R., Sehra,S., Goswami,R.,
Pham,D., Travers,J., Nguyen,E.T., Levy,D.E. and Kaplan,M.H.
(2011) The transcription factor STAT3 is required for T helper 2
cell development. Immunity, 34, 39–49.
19. Murray,P.J. (2006) Understanding and exploiting the endogenous
interleukin-10/STAT3-mediated anti-inflammatory response. Curr.
Opin. Pharmacol., 6, 379–386.
20. Takeda,K., Clausen,B.E., Kaisho,T., Tsujimura,T., Terada,N.,
Forster,I. and Akira,S. (1999) Enhanced Th1 activity and
development of chronic enterocolitis in mice devoid of Stat3 in
macrophages and neutrophils. Immunity, 10, 39–49.
21. Langlais,D., Couture,C., Balsalobre,A. and Drouin,J. (2008)
Regulatory network analyses reveal genome-wide potentiation of
LIF signaling by glucocorticoids and define an innate cell defense
response. PLoS Genet., 4, e1000224.
22. Langmead,B., Trapnell,C., Pop,M. and Salzberg,S.L. (2009)
Ultrafast and memory-efficient alignment of short DNA
sequences to the human genome. Genome Biol., 10, R25.
23. Zhang,Y., Liu,T., Meyer,C.A., Eeckhoute,J., Johnson,D.S.,
Bernstein,B.E., Nusbaum,C., Myers,R.M., Brown,M., Li,W. et al.
(2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol.,
9, R137.
24. McLean,C.Y., Bristor,D., Hiller,M., Clarke,S.L., Schaar,B.T.,
Lowe,C.B., Wenger,A.M. and Bejerano,G. (2010) GREAT
improves functional interpretation of cis-regulatory regions. Nat.
Biotechnol., 28, 495–501.
25. Ho,L., Miller,E.L., Ronan,J.L., Ho,W.Q., Jothi,R. and
Crabtree,G.R. (2011) esBAF facilitates pluripotency by
conditioning the genome for LIF/STAT3 signalling and by
regulating polycomb function. Nat. Cell Biol., 13, 903–913.
26. Ramadoss,P., Chiappini,F., Bilban,M. and Hollenberg,A.N.
(2010) Regulation of hepatic six transmembrane epithelial antigen
of prostate 4 (STEAP4) expression by STAT3 and CCAAT/
enhancer-binding protein alpha. J. Biol. Chem., 285, 16453–16466.
27. Dai,M., Wang,P., Boyd,A.D., Kostov,G., Athey,B., Jones,E.G.,
Bunney,W.E., Myers,R.M., Speed,T.P., Akil,H. et al. (2005)
Evolving gene/transcript definitions significantly alter the
interpretation of GeneChip data. Nucleic Acids Res., 33, e175.
28. Li,B. and Dewey,C.N. (2011) RSEM: accurate transcript
quantification from RNA-Seq data with or without a reference
genome. BMC Bioinformatics, 12, 323.
29. Heinz,S., Benner,C., Spann,N., Bertolino,E., Lin,Y.C., Laslo,P.,
Cheng,J.X., Murre,C., Singh,H. and Glass,C.K. (2010) Simple
combinations of lineage-determining transcription factors prime
cis-regulatory elements required for macrophage and B cell
identities. Molecular Cell, 38, 576–589.
30. Grant,C.E., Bailey,T.L. and Noble,W.S. (2011) FIMO: scanning
for occurrences of a given motif. Bioinformatics, 27, 1017–1018.
31. Gupta,S., Stamatoyannopoulos,J.A., Bailey,T.L. and Noble,W.S.
(2007) Quantifying similarity between motifs. Genome Biol., 8,
R24.
32. Newburger,D.E. and Bulyk,M.L. (2009) UniPROBE: an online
database of protein binding microarray data on protein-DNA
interactions. Nucleic Acids Res., 37, D77–D82.
33. Portales-Casamar,E., Thongjuea,S., Kwon,A.T., Arenillas,D.,
Zhao,X., Valen,E., Yusuf,D., Lenhard,B., Wasserman,W.W. and
Sandelin,A. (2010) JASPAR 2010: the greatly expanded
open-access database of transcription factor binding profiles.
Nucleic Acids Res., 38, D105–D110.
34. Stark,C., Breitkreutz,B.J., Chatr-Aryamontri,A., Boucher,L.,
Oughtred,R., Livstone,M.S., Nixon,J., Van Auken,K., Wang,X.,
Shi,X. et al. (2011) The BioGRID Interaction Database: 2011
update. Nucleic Acids Res., 39, D698–D704.
35. Mullen,A.C., Orlando,D.A., Newman,J.J., Loven,J., Kumar,R.M.,
Bilodeau,S., Reddy,J., Guenther,M.G., DeKoter,R.P. and
Young,R.A. (2011) Master transcription factors determine
cell-type-specific responses to TGF-beta signaling. Cell, 147,
565–576.
36. Schmidt,D., Wilson,M.D., Ballester,B., Schwalie,P.C.,
Brown,G.D., Marshall,A., Kutter,C., Watt,S., Martinez-
Jimenez,C.P., Mackay,S. et al. (2010) Five-vertebrate ChIP-seq
reveals the evolutionary dynamics of transcription factor binding.
Science, 328, 1036–1040.
37. Ouyang,Z., Zhou,Q. and Wong,W.H. (2009) ChIP-Seq of
transcription factors predicts absolute and differential gene
expression in embryonic stem cells. Proc. Natl Acad. Sci. USA,
106, 21521–21526.
38. Ramagopalan,S.V., Heger,A., Berlanga,A.J., Maugeri,N.J.,
Lincoln,M.R., Burrell,A., Handunnetthi,L., Handel,A.E.,
Disanto,G., Orton,S.M. et al. (2010) A ChIP-seq defined
genome-wide map of vitamin D receptor binding: associations
with disease and evolution. Genome Res., 20, 1352–1360.
39. Gu,F., Dube,N., Kim,J.W., Cheng,A., Ibarra-Sanchez Mde,J.,
Tremblay,M.L. and Boisclair,Y.R. (2003) Protein tyrosine
phosphatase 1B attenuates growth hormone-mediated
JAK2-STAT signaling. Mol. Cell. Biol., 23, 3753–3762.
40. Shuai,K. and Liu,B. (2003) Regulation of JAK-STAT signalling
in the immune system. Nat. Rev. Immunol., 3, 900–911.








ong Kong user on 15 February 2019
41. Gaba,A., Grivennikov,S.I., Do,M.V., Stumpo,D.J.,
Blackshear,P.J. and Karin,M. (2012) Cutting edge: IL-10-mediated
tristetraprolin induction is part of a feedback loop that controls
macrophage STAT3 activation and cytokine production.
J. Immunol, 189, 2089–2093.
42. El Kasmi,K.C., Smith,A.M., Williams,L., Neale,G.,
Panopoulos,A.D., Watowich,S.S., Hacker,H., Foxwell,B.M. and
Murray,P.J. (2007) Cutting edge: a transcriptional repressor and
corepressor induced by the STAT3-regulated anti-inflammatory
signaling pathway. J. Immunol., 179, 7215–7219.
43. Blake,J.A., Bult,C.J., Eppig,J.T., Kadin,J.A. and Richardson,J.E.
(2009) The Mouse Genome Database genotypes::phenotypes.
Nucleic Acids Res., 37, D712–D719.
44. Wei,L., Vahedi,G., Sun,H.W., Watford,W.T., Takatori,H.,
Ramos,H.L., Takahashi,H., Liang,J., Gutierrez-Cruz,G., Zang,C.
et al. (2010) Discrete roles of STAT4 and STAT6 transcription
factors in tuning epigenetic modifications and transcription during
T helper cell differentiation. Immunity, 32, 840–851.
45. Meijsing,S.H., Pufall,M.A., So,A.Y., Bates,D.L., Chen,L. and
Yamamoto,K.R. (2009) DNA binding site sequence directs
glucocorticoid receptor structure and activity. Science, 324,
407–410.
46. Becker,S., Groner,B. and Muller,C.W. (1998) Three-dimensional
structure of the Stat3beta homodimer bound to DNA. Nature,
394, 145–151.
47. Husby,J., Todd,A.K., Haider,S.M., Zinzalla,G., Thurston,D.E. and
Neidle,S. (2012) Molecular dynamics studies of the STAT3
homodimer:DNA Complex: relationships between STAT3 mutations
and protein-DNA recognition. J. Chem. Inform. Model, 52, 1179–1192.
48. Ogata,K., Sato,K. and Tahirov,T.H. (2003) Eukaryotic
transcriptional regulatory complexes: cooperativity from near and
afar. Curr. Opin. Struct. Biol., 13, 40–48.
49. Miranda-Saavedra,D. and Gottgens,B. (2008) Transcriptional
regulatory networks in haematopoiesis. Curr. Opin. Genet. Dev.,
18, 530–535.
50. Lian,I., Kim,J., Okazawa,H., Zhao,J., Zhao,B., Yu,J.,
Chinnaiyan,A., Israel,M.A., Goldstein,L.S., Abujarour,R. et al.
(2010) The role of YAP transcription coactivator in regulating
stem cell self-renewal and differentiation. Genes Dev., 24,
1106–1118.
51. Wang,J., Zhuang,J., Iyer,S., Lin,X., Whitfield,T.W., Greven,M.C.,
Pierce,B.G., Dong,X., Kundaje,A., Cheng,Y. et al. (2012)
Sequence features and chromatin structure around the genomic
regions bound by 119 human transcription factors. Genome Res.,
22, 1798–1812.
52. Johnson,R., Teh,C.H., Kunarso,G., Wong,K.Y., Srinivasan,G.,
Cooper,M.L., Volta,M., Chan,S.S., Lipovich,L., Pollard,S.M.
et al. (2008) REST regulates distinct transcriptional networks in
embryonic and neural stem cells. PLoS Biol., 6, e256.
53. Pardo,M., Lang,B., Yu,L., Prosser,H., Bradley,A., Babu,M.M.
and Choudhary,J. (2010) An expanded Oct4 interaction network:
implications for stem cell biology, development, and disease. Cell
Stem Cell, 6, 382–395.
54. Wang,J., Rao,S., Chu,J., Shen,X., Levasseur,D.N.,
Theunissen,T.W. and Orkin,S.H. (2006) A protein interaction
network for pluripotency of embryonic stem cells. Nature, 444,
364–368.
55. Russell,L. and Garrett-Sinha,L.A. (2010) Transcription factor
Ets-1 in cytokine and chemokine gene regulation. Cytokine, 51,
217–226.
56. Zhang,F., Wang,D.Z., Boothby,M., Penix,L., Flavell,R.A. and
Aune,T.M. (1998) Regulation of the activity of IFN-gamma
promoter elements during Th cell differentiation. J. Immunol.,
161, 6105–6112.
57. Xie,H., Ye,M., Feng,R. and Graf,T. (2004) Stepwise
reprogramming of B cells into macrophages. Cell, 117, 663–676.
58. Icardi,L., Mori,R., Gesellchen,V., Eyckerman,S., De Cauwer,L.,
Verhelst,J., Vercauteren,K., Saelens,X., Meuleman,P., Leroux-
Roels,G. et al. (2012) The Sin3a repressor complex is a master
regulator of STAT transcriptional activity. Proc. Natl Acad. Sci.
USA, 109, 12058–12063.
59. Vallania,F., Schiavone,D., Dewilde,S., Pupo,E., Garbay,S.,
Calogero,R., Pontoglio,M., Provero,P. and Poli,V. (2009)
Genome-wide discovery of functional transcription factor binding
sites by comparative genomics: the case of Stat3. Proc. Natl
Acad. Sci. USA, 106, 5117–5122.
60. Lee,B.K., Bhinge,A.A., Battenhouse,A., McDaniell,R.M., Liu,Z.,
Song,L., Ni,Y., Birney,E., Lieb,J.D., Furey,T.S. et al. (2012)
Cell-type specific and combinatorial usage of diverse transcription
factors revealed by genome-wide binding studies in multiple
human cells. Genome Res., 22, 9–24.
61. Trompouki,E., Bowman,T.V., Lawton,L.N., Fan,Z.P., Wu,D.C.,
DiBiase,A., Martin,C.S., Cech,J.N., Sessa,A.K., Leblanc,J.L. et al.
(2011) Lineage regulators direct BMP and Wnt pathways to
cell-specific programs during differentiation and regeneration.
Cell, 147, 577–589.
62. Frietze,S., Wang,R., Yao,L., Tak,Y.G., Ye,Z., Gaddis,M.,
Witt,H., Farnham,P.J. and Jin,V.X. (2012) Cell type-specific
binding patterns reveal that TCF7L2 can be tethered to the
genome by association with GATA3. Genome Biol., 13, R52.
63. Dang,C.V., O’Donnell,K.A., Zeller,K.I., Nguyen,T., Osthus,R.C.
and Li,F. (2006) The c-Myc target gene network. Semin. Cancer
Biol., 16, 253–264.
64. Basso,K. and Dalla-Favera,R. (2012) Roles of BCL6 in normal
and transformed germinal center B cells. Immunolog. Rev., 247,
172–183.
65. Boulon,S., Bertrand,E. and Pradet-Balade,B. (2012) HSP90 and
the R2TP co-chaperone complex: building multi-protein
machineries essential for cell growth and gene expression. RNA
Biol., 9, 148–154.
66. Diani-Moore,S., Ram,P., Li,X., Mondal,P., Youn,D.Y.,
Sauve,A.A. and Rifkind,A.B. (2010) Identification of the aryl
hydrocarbon receptor target gene TiPARP as a mediator of
suppression of hepatic gluconeogenesis by
2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a
corrective agent for this effect. J. Biol. Chem., 285, 38801–38810.
67. Jimenez,G., Shvartsman,S.Y. and Paroush,Z. (2012) The Capicua
repressor—a general sensor of RTK signaling in development and
disease. J. Cell Sci., 125, 1383–1391.
68. Kannan,Y., Yu,J., Raices,R.M., Seshadri,S., Wei,M.,
Caligiuri,M.A. and Wewers,M.D. (2011) IkappaBzeta augments
IL-12- and IL-18-mediated IFN-gamma production in human NK
cells. Blood, 117, 2855–2863.
69. Lessard,L., Stuible,M. and Tremblay,M.L. (2010) The two faces
of PTP1B in cancer. Biochim. Biophys. Acta, 1804, 613–619.
70. Lores,P., Visvikis,O., Luna,R., Lemichez,E. and Gacon,G. (2010)
The SWI/SNF protein BAF60b is ubiquitinated through a
signalling process involving Rac GTPase and the RING finger
protein Unkempt. FEBS J., 277, 1453–1464.
71. Maldonado,V. and Melendez-Zajgla,J. (2011) Role of Bcl-3 in
solid tumors. Mol. Cancer, 10, 152.
72. Passon,D.M., Lee,M., Rackham,O., Stanley,W.A., Sadowska,A.,
Filipovska,A., Fox,A.H. and Bond,C.S. (2012) Structure of the
heterodimer of human NONO and paraspeckle protein
component 1 and analysis of its role in subnuclear body
formation. Proc. Natl Acad. Sci. USA, 109, 4846–4850.
73. Perez-Leal,O. and Merali,S. (2012) Regulation of polyamine
metabolism by translational control. Amino Acids, 42, 611–617.
74. Takano,A., Zochi,R., Hibi,M., Terashima,T. and Katsuyama,Y.
(2010) Expression of strawberry notch family genes during
zebrafish embryogenesis. Dev. Dyn., 239, 1789–1796.
75. Walker,W., Zhou,Z.Q., Ota,S., Wynshaw-Boris,A. and Hurlin,P.J.
(2005) Mnt-Max to Myc-Max complex switching regulates cell
cycle entry. J. Cell Biol., 169, 405–413.
76. Watanabe,N., Madaule,P., Reid,T., Ishizaki,T., Watanabe,G.,
Kakizuka,A., Saito,Y., Nakao,K., Jockusch,B.M. and
Narumiya,S. (1997) p140mDia, a mammalian homolog of
Drosophila diaphanous, is a target protein for Rho small GTPase
and is a ligand for profilin. EMBO J., 16, 3044–3056.
77. Wyman,S.K., Knouf,E.C., Parkin,R.K., Fritz,B.R., Lin,D.W.,
Dennis,L.M., Krouse,M.A., Webster,P.J. and Tewari,M. (2011)
Post-transcriptional generation of miRNA variants by multiple
nucleotidyl transferases contributes to miRNA transcriptome
complexity. Genome Res., 21, 1450–1461.
78. Zhou,L., Zhang,Z., Zheng,Y., Zhu,Y., Wei,Z., Xu,H., Tang,Q.,
Kong,X. and Hu,L. (2011) SKAP2, a novel target of HSF4b,
associates with NCK2/F-actin at membrane ruffles and regulates
actin reorganization in lens cell. J. Cell. Mol. Med., 15, 783–795.








ong Kong user on 15 February 2019
